Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 6/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | DRD2 | P14416 | 1/20 | 0.50 |
| ▸ | DRD4 | P21917 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 5/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9808263 | 0.86 | L3MBTL1 (0.68) | MEN1PKMKMT2AL3MBTL1MAPT | |
| SCHEMBL2092541 | 0.82 | MEN1 (0.52) | MEN1PKMKMT2AL3MBTL1MAPT | |
| SCHEMBL11881226 | 0.80 | L3MBTL1 (0.79) | MEN1PKMKMT2AL3MBTL1MAPT | |
| SCHEMBL5824396 | 0.80 | L3MBTL1 (0.56) | MEN1PKMKMT2AL3MBTL1MAPT | |
| SCHEMBL5660214 | 0.80 | L3MBTL1 (0.59) | MEN1PKMKMT2AL3MBTL1MAPT | |
| SCHEMBL10458296 | 0.78 | L3MBTL1 (0.55) | MEN1PKMKMT2AL3MBTL1MAPT | |
| SCHEMBL7330452 | 0.78 | L3MBTL1 (0.55) | MEN1PKMKMT2AL3MBTL1MAPT | |
| SCHEMBL3790085 | 0.78 | L3MBTL1 (0.59) | MEN1PKMKMT2AL3MBTL1MAPT | |
| SCHEMBL1032880 | 0.78 | KDM4E (0.68) | MEN1PKMKMT2AL3MBTL1MAPT | |
| SCHEMBL72579 | 0.78 | L3MBTL1 (0.55) | MEN1PKMKMT2AL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0443560-A2 | HIV protease inhibitors | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1991-08-28 | — | — | EP | claimed |
| US-8163753-B2 | 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-04-24 | — | — | US | disclosed |
| EP-1678185-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMA CO LTD (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | OTSUKA PHAMACEUTICAL CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
| EP-1678185-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005042542-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-05-12 | — | — | WO | disclosed |
| EP-0295716-B1 | Process for the formation of color image and band stop filter used therefor | FUJI PHOTO FILM CO LTD (JP) | 1994-12-07 | — | — | EP | disclosed |
| US-5051447-A | Applying aromatic oximes to plants, seeds or soils | BASF AKTIENGESELLSCHAFT (DE) | 1991-09-24 | — | — | US | disclosed |
| EP-0443560-A2 | HIV protease inhibitors | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1991-08-28 | — | — | EP | disclosed |
| US-4997973-A | Ortho-substituted benzyl carboxylates and fungicides containing these compounds | BASF AKTIENGESELLSCHAFT (DE) | 1991-03-05 | — | — | US | disclosed |
| EP-0310954-B1 | ORTHO-SUBSTITUTED CARBOXYLIC ACID BENZYL ESTERS AND FUNGICIDES CONTAINING THESE COMPOUNDS | BASF Aktiengesellschaft (DE) | 1990-11-22 | — | — | EP | disclosed |
| US-4952720-A | Ortho-substituted benzyl carboxylates and fungicides which contain these compounds | BASF AKTIENGSELLSCHAFT (DE) | 1990-08-28 | — | — | US | disclosed |
| EP-0337211-B1 | ORTHO-SUBSTITUTED CARBOXYLIC-ACID BENZYL ESTERS AND FUNGICIDES CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1990-07-11 | — | — | EP | disclosed |
| EP-0354571-A1 | Oximethers, method for their preparation and fungicides containing them | BASF Aktiengesellschaft (DE) | 1990-02-14 | — | — | EP | disclosed |
| EP-0337211-A1 | Ortho-substituted carboxylic-acid benzyl esters and fungicides containing them | BASF Aktiengesellschaft (DE) | 1989-10-18 | — | — | EP | disclosed |
| EP-0310954-A1 | Ortho-substituted carboxylic acid benzyl esters and fungicides containing these compounds | BASF Aktiengesellschaft (DE) | 1989-04-12 | — | — | EP | disclosed |
| EP-0295716-A2 | Process for the formation of color image and band stop filter used therefor | FUJI PHOTO FILM CO., LTD. (JP) | 1988-12-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | NR2C2, NR0B2, NR4A2 | MEN1 4525/4885PKM 3041/4885KMT2A 3324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.